75 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
., August 21, 2023 (GLOBE NEWSWIRE) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation
8-K
EX-99.1
h1tustehbm8q1keo
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
EX-99.1
19jd khm8p5c6xr6
19 Jul 23
Regulation FD Disclosure
9:21am
424B3
ly2hmdh
29 Jun 23
Prospectus supplement
4:31pm
8-K
a9c4b427124kpp
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
1vr d8gn9amc
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
2swinlj2f vy1
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
8-K
EX-99.1
3s2faqq3
14 Dec 22
Entry into a Material Definitive Agreement
9:18am
DEFA14A
bf13pgje0p6365jk0k
12 Dec 22
Additional proxy soliciting materials
10:41am
8-K
EX-99.1
ott78fulrvu rdon6e1b
8 Nov 22
Entry into a Material Definitive Agreement
9:15am